Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

Table 1 Associations of population with available sTIL-0 values (n = 323) with clinical/pathological characteristics

Characteristic	Category	n	Mean sTIL-0 (%)	p value
Age at diagnosis*	≤ 50 yrs > 50 yrs	162 161	30.0 28.9	.68
Tumor stage	pT1 pT2-4	121 202	26.5 22.9	.10
Nodal status	Negative Positive	238 85	27.9 33.9	.049
Central grade	G 2 G 3	20 302	17.3 30.3	.021

*Median patient age at diagnosis was 50.5 yrs. (minimum 26 yrs., maximum 76 yrs.)

ISSN: 1465-542X